Clinical trial
Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in…
NCT00346983 · Johns Hopkins University, Other · Terminated
Key facts
| NCT number | NCT00346983 |
|---|---|
| Title | Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics |
| Official title | Pilot Study of the Effect of Pegaptanib Sodium to Prevent Worsening of Cystoid Macular Edema Following Cataract Surgery in Diabetics |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Eyetech Pharmaceuticals Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cystoid Macular Edema |
| Intervention type | Drug |
| Interventions | Pegaptanib sodium, Control |
| Enrollment | 4 |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | May 12, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: